Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

DAMCI, Taner; EMRAL, RIFAT; Svendsen, Anne; Balkir, Tanzer; Vora, Jiten

doi:10.1186/1472-6823-14-61

Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Atıf İçin Kopyala

DAMCI T., EMRAL R., Svendsen A. L., Balkir T., Vora J.

BMC ENDOCRINE DISORDERS, cilt.14, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14
Basım Tarihi: 2014
Doi Numarası: 10.1186/1472-6823-14-61
Dergi Adı: BMC ENDOCRINE DISORDERS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Insulin detemir, Insulin glargine, Basal insulin, Type 2 diabetes, Weight loss, Hypoglycaemia, LONG-ACTING INSULINS, BASAL INSULIN, GLYCOSYLATED HEMOGLOBIN, GLYCEMIC CONTROL, NAIVE PATIENTS, NPH INSULIN, ADD-ON, MANAGEMENT, ANALOGS, GLUCOSE
Ankara Üniversitesi Adresli: Evet

Özet

Background: The purpose of this analysis is to evaluate the safety and effectiveness of insulin initiation with once-daily insulin detemir (IDet) or insulin glargine (IGlar) in real-life clinical practice in Turkish patients with type 2 diabetes mellitus (T2DM).